Aktie A2JHC5 ALEAFIA HEALTH INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Aleafia Health Inc.

Aktien

A2JHC5

CA01444Q1046

AH

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Red White & Bloom Brands Inc. completed the acquisition of One Plant Corp. and Certain assets of Aleafia Health Inc. for CAD 31.7 million.
Red White & Bloom Brands Inc. entered into a stalking horse asset purchase agreement to acquire One Plant Corp. and Certain assets of Aleafia Health Inc.
Red White & Bloom Says Court Approves Stalking Horse Bid for Purposes of Aleafia Health's CCAA Sale
Red White & Bloom Offers Update on Existing Aleafia Health Secured Loan; Reports New Debtor-in-Possession Financing for Aleafia
Aleafia Health Obtains Creditor Protection to Pursue Restructuring Process
Red White & Bloom Brands Brief: Providing Update on Existing Aleafia Health Secured Loan and Announcing New Debtor-in-Possession Financing for Aleafia Health
Canadian Investment Regulatory Organization Trading Halt - AH
Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process
Aleafia and Red White & Bloom Brands Cancel Planned Merger
Aleafia Health Brief: Red White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement
Red White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement
Red White & Bloom Brands Inc. cancelled the acquisition of Aleafia Health Inc. (TSX:AH) from shareholders.
Aleafia Health Announces In-Kind Payment of Interest on Secured Convertible Debentures
Aleafia Health Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
Aleafia Health Brief: Red White & Bloom Recently Executed Binding Letter Agreement To Buy Aleafia and Affiliates
Aleafia Health Brief: Says Third consecutive quarter of positive Adjusted EBITDA achieved in Q4 FY2023
Aleafia Health Brief: Net revenue increased 33% to $9.4 million for Q4 FY2023 versus $7.0 million for the period ended March 31, 2022
Aleafia Health Brief: Revenue increased 9% to $11.7 million for the period ended March 31, 2023 (Q4 FY2023) versus $10.7 million for the period ended March 31, 2022
Aleafia Health Announces Fourth Quarter and Annual Financial Results
Aleafia Health Inc. Reports Impairment of Property, Plant & Equipment for the Fourth Quarter Ended March 31, 2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2JHC5 Aktie
  4. Nachrichten Aleafia Health Inc.
  5. Andere Sprachen